Predictions
Seagen Inc.
Start price
Target price
Perf. (%)
€152.08
07.09.22
07.09.22
€180.00
31.12.24
31.12.24
21.00%
21.03.23
21.03.23
Could be very worthwhile Investment >20% year
Ocuphire Pharma Inc.
Start price
Target price
Perf. (%)
€2.58
07.02.22
07.02.22
€3.20
07.02.23
07.02.23
26.55%
08.02.23
08.02.23
Kala Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€32.60
28.12.22
28.12.22
€40.00
28.12.23
28.12.23
50.15%
02.01.23
02.01.23
Biogen Inc.
Start price
Target price
Perf. (%)
€208.25
27.12.21
27.12.21
€215.00
27.12.22
27.12.22
23.82%
28.12.22
28.12.22
Could be worthwhile Investment >10% per year
Aptevo Therapeutics Inc.
Start price
Target price
Perf. (%)
€5.53
12.12.22
12.12.22
€5.00
12.12.23
12.12.23
-33.60%
12.12.22
12.12.22
Johnson & Johnson
Start price
Target price
Perf. (%)
€140.70
27.11.21
27.11.21
€160.00
27.11.22
27.11.22
21.35%
28.11.22
28.11.22
Could be worthwhile Investment >10% per year
Significant cyclical dependencies
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€533.60
09.11.21
09.11.21
€600.00
09.11.22
09.11.22
38.91%
10.11.22
10.11.22
Could be worthwhile Investment >10% per year
Revance Therapeutics Inc.
Start price
Target price
Perf. (%)
€12.40
01.11.21
01.11.21
€15.00
01.11.22
01.11.22
79.03%
02.11.22
02.11.22
Could be worthwhile Investment >10% per year
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€338.70
07.10.22
07.10.22
€350.00
07.10.23
07.10.23
7.12%
29.10.22
29.10.22
Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€59.87
15.05.22
15.05.22
€68.00
15.05.23
15.05.23
32.12%
28.10.22
28.10.22
Could be worthwhile Investment >10% per year
positive Cash Flow expected
ROE higher than 15% per year
Normal challenges to pay loans and raise capital
Avenue Therapeutics Inc.
Start price
Target price
Perf. (%)
€10.50
01.10.22
01.10.22
€5.00
01.10.23
01.10.23
-70.29%
15.10.22
15.10.22
Flexion Therapeutics Inc.
Start price
Target price
Perf. (%)
€5.25
27.09.21
27.09.21
€8.00
27.09.22
27.09.22
53.33%
28.09.22
28.09.22
Chemocentryx Inc.
Start price
Target price
Perf. (%)
€29.94
20.10.21
20.10.21
€35.00
31.12.23
31.12.23
65.15%
05.08.22
05.08.22
Could be very worthwhile Investment >20% year
Global Blood Therapeutics Inc
Start price
Target price
Perf. (%)
€33.09
30.10.21
30.10.21
€45.00
31.12.23
31.12.23
94.65%
05.08.22
05.08.22
Could be very worthwhile Investment >20% year
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€152.65
16.11.21
16.11.21
€200.00
31.01.25
31.01.25
36.59%
03.08.22
03.08.22
Could be worthwhile Investment >10% per year
Forte Biosciences Inc.
Start price
Target price
Perf. (%)
€1.19
27.06.22
27.06.22
€1.00
27.06.23
27.06.23
26.17%
09.07.22
09.07.22
Capable Management
Could be very worthwhile Investment >20% year
Few uniques
Agile Therapeutics Inc.
Start price
Target price
Perf. (%)
€79.50
27.06.22
27.06.22
€100.00
27.06.23
27.06.23
40.88%
28.06.22
28.06.22
Could be worthwhile Investment >10% per year
Capable Management
Very good company culture
Little innovation
Kezar Life Sciences
Start price
Target price
Perf. (%)
€10.20
16.11.21
16.11.21
€11.00
31.12.24
31.12.24
0.98%
28.06.22
28.06.22
Could be very worthwhile Investment >20% year
Bluebird Bio Inc.
Start price
Target price
Perf. (%)
€9.23
09.11.21
09.11.21
€7.00
31.12.23
31.12.23
-56.18%
28.06.22
28.06.22
Could be very worthwhile Investment >20% year
Cti Biopharma Corp
Start price
Target price
Perf. (%)
€2.47
17.10.21
17.10.21
€4.00
31.12.23
31.12.23
112.17%
28.06.22
28.06.22
Could be very worthwhile Investment >20% year
Forte Biosciences Inc.
Start price
Target price
Perf. (%)
€1.10
13.06.22
13.06.22
€1.00
13.06.23
13.06.23
7.81%
25.06.22
25.06.22
Capable Management
Could be very worthwhile Investment >20% year
Few uniques